CAJ | 학술논문

企业研发投入行为能客观反映企业创新活跃程度，进而反映产业或国家的创新能力。基于欧盟产业研发投入报告所提供的数据，分析制药和生物科技高研发投入企业特征，对比分析中国与美国、日本、韩国、英国、法国、德国和印度7个国家的制药和生物科技企业研发投入的差异。研究发现，中国制药和生物科技企业的研发投入虽然增长迅速，但是制药和生物科技产业依然被美国、日本和欧盟所统治，中国高研发投入企业在制药和生物科技产业覆盖率非常低，在研发投入和研发强度上与美国、日本、韩国、英国、法国和德国等国家还存在巨大差距；同时，在研发投入、研发强度和盈利能力等方面，中国已经全面落后于印度。为了解我国制药和生物科技企业研发投入现状，推进创新型国家建设提供借鉴。
기업연발투입행위능객관반영기업창신활약정도，진이반영산업혹국가적창신능력。기우구맹산업연발투입보고소제공적수거，분석제약화생물과기고연발투입기업특정，대비분석중국여미국、일본、한국、영국、법국、덕국화인도7개국가적제약화생물과기기업연발투입적차이。연구발현，중국제약화생물과기기업적연발투입수연증장신속，단시제약화생물과기산업의연피미국、일본화구맹소통치，중국고연발투입기업재제약화생물과기산업복개솔비상저，재연발투입화연발강도상여미국、일본、한국、영국、법국화덕국등국가환존재거대차거；동시，재연발투입、연발강도화영리능력등방면，중국이경전면락후우인도。위료해아국제약화생물과기기업연발투입현상，추진창신형국가건설제공차감。
Enterprise R&D investment can represent the enterprise innovation activity,and reflect a country's or industry innovation ability.Based on the data from EU industrial R&D investment scoreboard,this paper analyzed enterprise features with high R&D investment in pharmaceuticals &biotechnology industry,and compared the difference of pharmaceuticals &biotechnology enterprise R&D investment between China and USA,Japan,South Korea,Britain,France ,Germany and India.Study showed that R&D investment of pharmaceuticals &biotechnology company in China grew rapidly,but the in-dustry was still dominated by USA,Japan and European,and the coverage rate in pharmaceuticals &biotechnology industry of China top R&D investors was low;there was a huge gap of R&D and R&D intensity between China and USA,Japan, South Korea,Britain,France and Germany,at the same time,R&D,R&D intensity and profitability of pharmaceuticals &biotechnology industry in China were far behind that of India.This research is meaningful to understand the current status of pharmaceuticals &biotechnology enterprise R&D investment in China.